A selection of blockbuster announcements

1. China Software International: sign a cooperation framework agreement with New World payment technology to start the in-depth development of OpenHarmony.

China Software International announced that Shenzhen China soft International Technology Service Co., Ltd., a wholly-owned subsidiary of the company, has reached a strategic cooperation with New Continental payment Technology, a wholly-owned subsidiary of New World. The two sides launched the in-depth development of the OpenHarmony operating system applied to the financial intelligent terminal, promoted the upgrading of the core of the financial intelligent terminal, and realized the ecological system construction of "AloT+ finance + digital intelligent transformation" in a three-dimensional way.

2. Xinte Energy: signed the strategic cooperation sale and purchase agreement of polysilicon, with a total transaction value of 17.468 billion yuan.

Xinte Energy announced that on September 22, 2021, the company, its subsidiaries Xinjiang Xinte Crystal Silicon Hi-Tech Co., Ltd. and Inner Mongolia Xinte Silicon material Co., Ltd. signed a strategic polysilicon trading agreement with Shuangliang Silicon material. According to the Strategic Cooperative Sale Agreement, the Group will sell a total of 82200 tons of polysilicon to Shuangliang Silicon from January 2022 to December 2026, and the order price will be determined on a monthly basis. If calculated according to the polysilicon price announced by the Silicon Branch of China Nonferrous Metals Industry Association, the total transaction amount under the strategic cooperation sale agreement is about 17.468 billion yuan (including tax).

3. CIMC vehicles: controlling shareholder CIMC Hong Kong increased its holding of 101 million H shares

CIMC announced that on September 22, 2021, the company received notice from its controlling shareholder China International Marine Containers that its wholly-owned subsidiary CIMC Hong Kong purchased about 101 million H shares of the company at an average price of HK $6.7702 per share through open market bulk transactions on September 21, 2021, the total amount is about HK $681 million (excluding related transaction fees).

4. Yasheng Pharmaceutical-B:MDM2-p53 inhibitor APG-115 is qualified for FDA fast track.

Yasheng Pharmaceutical-B announced that the company is developing the original new drug MDM2-p53 inhibitor alrizomadlin (APG-115) to obtain fast-track qualification (FTD) granted by the US Food and Drug Administration (FDA) for patients with recurrent "refractory unresectable" metastatic melanoma after tumor immunotherapy.

5. Chinese home buyers: a total of 109 million shares of China Evergrande Group have been sold.

Chinese Real Estate announced on the Hong Kong Stock Exchange that between August 30 and September 21, a total of 109 million shares of China Evergrande Group Group were sold through the open market of the Stock Exchange, with a total consideration of about HK $246.5 million. All remaining China Evergrande Group shares may be sold, and a loss of HK $9.5 billion is expected.

• New shares listed

Tam Tsai International (02217) launched its initial public offering on September 23 at a price of HK $3.33 to HK $4.17 per share.

Maxwell Medical-B (02216) Public offering is 11.13 times subscribed at a price of HK $18.70 per share

• Important matters

China Minsheng Banking Corp (01988) agreed to adjust the total budget for non-credit related transactions of Minsheng e-commerce to 3.218 billion yuan.

China Software International (00354) and New World payment Technology signed a cooperation framework agreement to launch the OpenHarmony operating system development in the field of financial intelligent terminals.

• Financial report data

The average daily gold output of Shandong Gold Mining's (01787) mine in September was about 82% of that of the same period last year.

• Bond bill

Huatai (06886) has completed the issuance of perpetual subordinated bonds in 2021 (the first tranche).

China International Capital Corporation (03908) will redeem all 2016 corporate bonds (second issue)

Hongan Group (01222) subsidiary intends to acquire $3.88 million of notes issued by pattern year Holdings (01777).

CSC FINANCIAL CO.,LTD (06066) has completed the issue of the 14th issue of 2021 short-term financing bills with a coupon of 2.75% per annum.

• Investment and operation

New Special Energy (01799) signed a strategic cooperation sale and purchase agreement for polysilicon, with a total transaction value of 17.468 billion yuan.

Yasheng Medicine-B (06855): MDM2-p53 inhibitor APG-115 is qualified for FDA fast track in the treatment of recurrent "refractory unresectable" metastatic melanoma

INNOVENT BIO (01801): application for new indications of NMPA lidabesu ®(Xindirizumab injection) combined with chemotherapy in the treatment of first-line esophageal squamous cell carcinoma

Genting Xinyao-B (01952) carries out multi-target cooperation with AbCellera to promote the research and development of new antibody drugs.

Green Leaf Pharmaceuticals (02186) the Mingduo patch of the new drug Lis has been approved for sale in the UK.

CSPC Pharmaceutical (01093) enters into a strategic alliance agreement with Conoya

Genscript Biotech Corporation (01548): Legend Biotech Corp will hold the first R & D Day in New York on October 18th.

• Increase and decrease holdings
  

CIMC vehicle (01839): controlling shareholder CIMC Hong Kong increased its holding of 101 million H shares

Chinese Real Estate (00127): cumulative sale of a total of 109 million shares of China Evergrande Group